Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

"Understanding the rates of false-positives and false-negatives in lymph node assessment allows for better-informed surgical decision-making. This contributes to determining the extent of LN ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

Patients with prior malignancy showed improved cancer-specific survival in metastatic colorectal cancer (mCRC), but prior skin tumors or malignancies diagnosed over five years earlier worsened ...

mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...

Zanzalintinib plus atezolizumab showed significant survival benefits over regorafenib in non-MSI-high metastatic colorectal cancer patients in the STELLAR-303 trial. The trial's safety profile was ...

The tool scans digital images of the same cancer tissue samples that pathologists use and can tell how fast the cancer is ...